Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In its off-label use for anti-aging or bodybuilding, it is used in doses of 200 to 300 g taken subcutaneously 2-3 times per day due to the short half-life
Postprandial glucose levels (measured two hours after eating) decreased by 36%
What the Research Actually Shows Published research on AOD-9604 describes: Modest body fat reduction in preclinical and early clinical settings Reduced triglycerides in some studies Minimal effect on IGF-1 confirmed across the clinical dataset Good tolerability adverse event rates in the phase 2 obesity trials were comparable to placebo Variable weight loss some patients respond better than others, consistent with many metabolic interventions The effect size in phase 2 obesity trials was modest typically in the range of a few pounds over the study period
48 , e245 (2016)
